Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 16/20 | 0.44 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | MET | P08581 | 2/20 | 0.39 |
| ▸ | SPR | P35270 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 2/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.37 |
| ▸ | INSR | P06213 | 2/20 | 0.36 |
| ▸ | LCK | P06239 | 2/20 | 0.36 |
| ▸ | LTK | P29376 | 2/20 | 0.36 |
| ▸ | AXL | P30530 | 2/20 | 0.36 |
| ▸ | IRAK1 | P51617 | 2/20 | 0.36 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.36 |
| ▸ | MERTK | Q12866 | 2/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
| ▸ | FLT3 | P36888 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572514 | 1.00 | ALK (0.44) | ALKMAP3K7IRAK4METSPR | |
| SCHEMBL10270391 | 0.89 | ALK (0.52) | ALKMAP3K7IRAK4METSPR | |
| SCHEMBL572516 | 0.89 | ALK (0.52) | ALKMAP3K7IRAK4METSPR | |
| SCHEMBL572476 | 0.82 | SPR (0.59) | ALKMETSPRINSRLCK | |
| SCHEMBL572884 | 0.82 | SPR (0.44) | ALKMAP3K7IRAK4METSPR | |
| SCHEMBL15192746 | 0.81 | SPR (0.55) | ALKMAP3K7IRAK4METSPR | |
| SCHEMBL10270135 | 0.80 | ALK (0.67) | ALKMETSPRINSRLCK | |
| SCHEMBL15192258 | 0.80 | ALK (0.67) | ALKMETSPRINSRLCK | |
| SCHEMBL10270100 | 0.78 | ALK (0.52) | ALKMAP3K7IRAK4METSPR | |
| SCHEMBL572239 | 0.78 | ALK (0.60) | ALKMAP3K7IRAK4METSPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611784-A1 | BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE | Amgen, Inc (US) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012018668-A1 | BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE | AMGEN INC. (US) | 2012-02-09 | — | — | WO | disclosed |